Literature DB >> 14557863

The TCCS-A short measure to evaluate treatment-related coping and compliance in hospitalised childhood cancer patients and their primary caregivers.

Rosemarie Felder-Puig1, Alain di Gallo, Marion Waldenmair, Helmut Gadner, Reinhard Topf.   

Abstract

GOALS: This report describes the development and validation of a short rating system to assess treatment-related coping and compliance (TCC) in childhood cancer patients and their primary caregivers. PATIENTS AND METHODS: The initial system contained 21 items referring to supportive parenting style of the caregiver, treatment-related attitudes and behaviour of both caregiver and child, communicative skills of the child and relationships with the health care team. This questionnaire was completed independently by a nurse, a nursery-school teacher, a psychologist and a physician who are all working full time at the oncology unit. The sample under study included 111 patients aged 3-18 years who were on treatment, as well as their caregivers (in most cases the mother).
RESULTS: Using defined rules for item reduction, the questionnaire was reduced to 14 items, of which seven were referring to the TCC of the child and seven to the TCC of the caregiver. Cronbach's alpha coefficients ranged from 0.81 to 0.91 across the different assessments, indicating high internal consistency reliability. There was moderate to high agreement amongst observers (intra-class correlation coefficients ranged between 0.50 and 0.68). Construct validity was confirmed by a significant association between a global rating of TCC and the instrument's summary scores in the four assessments.
CONCLUSIONS: Our system may be used for clinical trials and clinical monitoring. Further testing of psychometric properties is recommended.

Entities:  

Mesh:

Year:  2003        PMID: 14557863     DOI: 10.1007/s00520-003-0541-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  23 in total

Review 1.  Scientific inquiry in childhood cancer psychosocial research. Theoretical, conceptual, and methodologic issues in the investigation and behavioral treatment of procedure-related distress.

Authors:  P J Carpenter
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

2.  Attributions, coping, and adjustment in children with cancer.

Authors:  N C Frank; R L Blount; R T Brown
Journal:  J Pediatr Psychol       Date:  1997-08

3.  Family coping with childhood leukemia: one year after diagnosis.

Authors:  M J Kupst; J L Schulman; G Honig; H Maurer; E Morgan; D Fochtman
Journal:  J Pediatr Psychol       Date:  1982-06

4.  Repressive adaptation in children with cancer.

Authors:  S Phipps; D K Srivastava
Journal:  Health Psychol       Date:  1997-11       Impact factor: 4.267

5.  Repressive adaptive style in children with chronic illness.

Authors:  Sean Phipps; Ric Steele
Journal:  Psychosom Med       Date:  2002 Jan-Feb       Impact factor: 4.312

6.  Treatment adherence difficulties among children with cancer: the role of parenting style.

Authors:  S L Manne; P B Jacobsen; K Gorfinkle; F Gerstein; W H Redd
Journal:  J Pediatr Psychol       Date:  1993-02

7.  Differences between high and low coping children and between parent and staff behaviors during painful medical procedures.

Authors:  R L Blount; B Landolf-Fritsche; S W Powers; J W Sturges
Journal:  J Pediatr Psychol       Date:  1991-12

8.  Avoidant coping in children with cancer.

Authors:  S Phipps; D Fairclough; R K Mulhern
Journal:  J Pediatr Psychol       Date:  1995-04

9.  Physician and parent behavior during invasive pediatric cancer procedures: relationships to child behavioral distress.

Authors:  L M Dahlquist; T G Power; L Carlson
Journal:  J Pediatr Psychol       Date:  1995-08

10.  Parent and adolescent adjustment to pediatric cancer: associations with coping, social support, and family function.

Authors:  Peter C Trask; Amber G Paterson; Christine L Trask; Cristina B Bares; JoAnn Birt; Cathy Maan
Journal:  J Pediatr Oncol Nurs       Date:  2003 Jan-Feb       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.